China Pharma Holdings (CPHI) Change in Cash (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Change in Cash came in at -$176638.0 in Q1 2026, up 17.53% YoY from -$150288.7 in Q1 2025, and down 327.96% on a QoQ basis from $77487.0 in Q4 2025.
China Pharma Holdings (CPHI) Change in Cash (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Change in Cash data on file, last reported at -$176638.0 in Q1 2026.
- Quarterly Change in Cash rose 17.53% year-over-year to -$176638.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$244214.0 (up 42.7% YoY) and the FY2025 annual result came in at -$281767.0, up 64.64% from the prior year.
- Change in Cash fell to -$176638.0 in Q1 2026, from $77487.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $467961.0 in Q3 2023 to a low of -$1.5 million in Q2 2022.
- A 5-year average of -$275916.8 and a median of -$158664.0 in 2022 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2023 — Change in Cash soared 394.94% — and 2025, when it tumbled 1631.12%.
- Tracing CPHI's Change in Cash over 5 years: stood at -$56327.0 in 2022, then surged by 195.81% to $53967.0 in 2023, then sank by 270.13% to -$91812.0 in 2024, then jumped by 184.4% to $77487.0 in 2025, then tumbled by 327.96% to -$176638.0 in 2026.
- The last three Change in Cash figures came in at -$176638.0 (Q1 2026), $77487.0 (Q4 2025), and -$357407.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | 136,400.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -176,638.00 |
| Dec 31, 2025 | 77,487.00 |
| Sep 30, 2025 | -357,407.00 |
| Jun 30, 2025 | 212,344.00 |
| Mar 31, 2025 | -214,191.00 |
| Dec 31, 2024 | -91,812.00 |
| Sep 30, 2024 | -20,646.00 |
| Jun 30, 2024 | -99,544.00 |
| Mar 31, 2024 | -584,957.00 |
| Dec 31, 2023 | 53,967.00 |
| Sep 30, 2023 | 467,961.00 |
| Jun 30, 2023 | -265,037.00 |
| Mar 31, 2023 | -863,024.00 |
| Dec 31, 2022 | -56,327.00 |
| Sep 30, 2022 | -158,664.00 |
| Jun 30, 2022 | -1.47 Mn |
| Mar 31, 2022 | -1.14 Mn |
| Dec 31, 2021 | 4.40 Mn |
| Sep 30, 2021 | -1.30 Mn |
| Jun 30, 2021 | 1.22 Mn |